Related content

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease

By Toledo Jon   Korff Ane   Shaw Leslie   Trojanowski John   Zhang Jing  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 683-697

Springer Publishing Company

Access to resources Recommend Favorite

Apo-Eε4 Allele in Conjunction with A&bgr;42 and Tau in CSF: Biomarker for Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 8, Iss. 2, 2011-03 ,pp. : 187-196

Bentham Science Publishers

Access to resources Recommend Favorite

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia

By Laske Christoph  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 80-85

Springer Publishing Company

Access to resources Recommend Favorite

Neurodegenerative disease biomarkers Aβ_1–40, Aβ_1–42, tau, and p‐tau₁₈₁ in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy

By  

Brain And Behavior, Vol. 8, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Longitudinal evaluation of Tau‐P301L transgenic mice reveals no cognitive impairments at 17 months of age

By  

Brain And Behavior, Vol. 8, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite